Nathan Wylie Bartlett

Title: Nathan Wylie Bartlett: Innovator in Rhinovirus Research

Introduction

Nathan Wylie Bartlett is a notable inventor based in Newcastle, GB. He has made significant contributions to the field of immunology, particularly in the development of innovative approaches to combat rhinovirus infections. His work is characterized by a focus on the induction of cross-reactive cellular responses against rhinovirus antigens.

Latest Patents

Nathan Wylie Bartlett holds a patent for the "Induction of cross-reactive cellular response against rhinovirus antigens." This invention involves an isolated peptide that comprises an amino acid sequence at least 90% identical to the VP4 amino acid sequence of a rhinovirus. Additionally, it includes an isolated polynucleotide encoding said peptide, which is placed under the control of elements necessary for its expression in a mammalian cell. The patent also covers an isolated peptide with a sequence of at least 100 amino acids that is at least 90% identical to a sequence located in the last 363 C-terminal amino acids of the RNA polymerase of a rhinovirus. Furthermore, it describes a Th1 adjuvant when the immunogenic composition comprises one or more of the isolated peptides.

Career Highlights

Throughout his career, Nathan Wylie Bartlett has demonstrated a commitment to advancing scientific knowledge and developing practical solutions to health challenges. His innovative work has positioned him as a key figure in the field of virology and immunology.

Collaborations

Nathan has collaborated with notable colleagues, including Walton Ross and Bruno Guy. These partnerships have contributed to the success of his research and the development of his patented technologies.

Conclusion

Nathan Wylie Bartlett is a distinguished inventor whose work in rhinovirus research has the potential to impact public health significantly. His innovative approaches and collaborations highlight his dedication to advancing the field of immunology.